EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comprehensive Analysis of Free BDPE Content in Commercial Hyaluronic Acid Fillers: Implications for Safety Assessment and Regulatory Standards

Cheol Joo Kim iD, Mirou Lee iD, Hyeongtaek Park iD, Jaeyoung Jo, Hyolim Lee, Pius J Seo, Seung Jun Shin iD, Chulho Shin iD

Journal of Cosmetic Dermatology · 2026

DOI: 10.1111/jocd.70790 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, 2026. Verfasst von Cheol Joo Kim und 7 weiteren Autor:innen. Beteiligte Einrichtung: R&D Department, Across Co. Ltd., Chuncheon, Republic of Korea. Hauptthemen laut MEDLINE: Hyaluronic Acid, Dermal Fillers, Butylene Glycols, Epoxy Compounds. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Although manufacturers of 1,4‐butanediol diglycidyl ether (BDDE)‐cross‐linked hyaluronic acid (HA) fillers assert effective removal of unreacted BDDE, the hydrolyzed derivative 3,3′‐(butane‐1,4‐diyl)bis(oxy)bis(propane‐1,2‐diol) (BDPE) is routinely monitored, despite possessing structural features associated with sensitization potential.

Aims

To quantify free BDPE content across commercially available HA dermal fillers and assess potential safety implications. Materials/Methods A validated liquid chromatography–tandem mass spectrometry method was developed to quantify BDPE levels in 38 commercial HA filler products from seven major manufacturers. In silico prediction models were used to evaluate the skin sensitization and irritation potential of BDPE.

Results

BDDE levels were non‐detectable in all analyzed products. By contrast, free BDPE content varied markedly, with over 1000‐fold differences observed between products, indicating substantial variability in purification efficiency across manufacturing processes. Considerable variability was also identified among Food and Drug Administration–approved products, with some containing BDPE concentrations exceeding 100 ppm. Conversely, several products exhibited low BDPE levels ranging from 0.1 to 2.5 ppm, further highlighting inconsistencies in manufacturing control.

Conclusions

Industry claims regarding complete cross‐linker removal may fail to account for the persistence of BDPE species. The substantial inter‐product variability observed in this study suggests inadequate process control among manufacturers. Given the structural similarity of BDPE to known sensitizers and the direct dermal injection route that circumvents the skin barrier, free BDPE should be designated a critical quality attribute with defined acceptance limits. These findings suggest that BDPE can be reduced to concentrations below 2.5 ppm, supporting the need for stricter manufacturing standards.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyaluronic AcidDermal FillersButylene GlycolsEpoxy CompoundsHumansTandem Mass SpectrometryLiquid Chromatography-Mass SpectrometryChromatography, Liquid

Stichwörter der Autor:innen

BDDEBDPEcross‐linked hyaluronatecross‐linkerdermal fillersodium hyaluronate

Substanzen

Hyaluronic AcidDermal Fillers1,4-bis(2,3-epoxypropoxy)butaneButylene GlycolsEpoxy Compounds

Autor:innen und Institutionen

  • R&D Department, Across Co. Ltd., Chuncheon, Republic of Korea.
  • Department of Medical Affairs, Hugel Inc., Seoul, Republic of Korea.

ORCID-Profile: Cheol Joo Kim, Mirou Lee, Hyeongtaek Park, Seung Jun Shin, Chulho Shin

Zitieren

APA

Kim, C. J., Lee, M., Park, H., Jo, J., Lee, H., Seo, P. J., Shin, S. J., & Shin, C. (2026). Comprehensive Analysis of Free BDPE Content in Commercial Hyaluronic Acid Fillers: Implications for Safety Assessment and Regulatory Standards. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70790

Vancouver

Kim CJ, Lee M, Park H, Jo J, Lee H, Seo PJ, et al. Comprehensive Analysis of Free BDPE Content in Commercial Hyaluronic Acid Fillers: Implications for Safety Assessment and Regulatory Standards. Journal of Cosmetic Dermatology. 2026. doi:10.1111/jocd.70790

BibTeX
@article{Kim2026,
  author = {Kim, Cheol Joo and Lee, Mirou and Park, Hyeongtaek and Jo, Jaeyoung and Lee, Hyolim and Seo, Pius J and Shin, Seung Jun and Shin, Chulho},
  title = {Comprehensive Analysis of Free BDPE Content in Commercial Hyaluronic Acid Fillers: Implications for Safety Assessment and Regulatory Standards},
  journal = {Journal of Cosmetic Dermatology},
  year = {2026},
  doi = {10.1111/jocd.70790}
}
Kostenlos starten →